News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Deals
Roche Holding AG Boosts Position in Diabetes Market with Buy; To Make Upfront Payment of $160 Million for Medingo
April 13, 2010
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
Reuters -- Roche Holding AG (ROG.VX) has bolstered its position in the diabetes market by buying Elron Electronics' (ELRN.TA) Medingo unit in a deal worth up to $200 million, the Swiss drugmaker said on Tuesday.
Twitter
LinkedIn
Facebook
Email
Print
Mergers & acquisitions
MORE ON THIS TOPIC
Autoimmune disease
Sanofi Taps Dren Again in up to $1.7B Autoimmune Partnership
December 15, 2025
·
1 min read
·
Annalee Armstrong
Mergers & acquisitions
Sobi Makes $1.5B Gout Play With Arthrosi Acquisition
December 15, 2025
·
2 min read
·
Tristan Manalac
Mergers & acquisitions
Pfizer Is Not a Done Dealmaker After Metsera Buy, With $6B More To Spend
December 10, 2025
·
1 min read
·
Annalee Armstrong
Japan
Japanese Pharmas Looking Beyond Borders for M&A to US, EU
December 10, 2025
·
7 min read
·
Dan Samorodnitsky